D
Spero Therapeutics, Inc. SPRO
$1.87 $0.010.54% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -407.08% -398.09% -400.65% 317.66% 273.10%
Total Depreciation and Amortization -100.00% -99.21% -99.46% -91.27% -75.62%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -51.16% -40.42% -37.81% -36.01% 42.25%
Change in Net Operating Assets 130.77% 153.89% 151.56% -295.06% -503.09%
Cash from Operations -124.78% -135.03% 28.95% -160.51% -218.80%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -99.99% -98.91%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -- -- -- -99.99% -98.91%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -128.29% -138.75% 28.47% -140.42% -143.86%